SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-23-000095
Filing Date
2023-05-23
Accepted
2023-05-23 16:31:58
Documents
12
Period of Report
2023-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K isee-20230517.htm   iXBRL 8-K 72185
  Complete submission text file 0001410939-23-000095.txt   214367

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20230517.xsd EX-101.SCH 1921
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20230517_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20230517_pre.xml EX-101.PRE 12525
6 EXTRACTED XBRL INSTANCE DOCUMENT isee-20230517_htm.xml XML 10555
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 23949323
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences